Abstract

Subclavian artery disease (SCAD) was not a rare disease in cardiovascular centers because the prevalence of SCAD was achieved in about 3–10% in patients with atherosclerotic disease. However, the indication or strategy of revascularization remains unclear. It has been reported that the primary or secondary patency after primary stenting for symptomatic SCAD was promising for a long time. It should be considered that endovascular procedure for SCAD have a risk of severe complication such as a cerebral infarction. Thus, the indication of revacularization or procedures should be determined cautiously. Based on historical reports or our findings, we reports the indication, procedures, initial success, complications, and long-term outcome.